小智港股覆盤 | 6月21日
今日,港股三大指數集體上漲。截止收盤,恆生指數漲1.87%,報21559點。國企指數大漲2.03%,報7549點。恆生科技指數大漲2.21%,報4760點。市場約1052只個股上漲,587只個股下跌。成交額突破1193.62億港幣,和昨天同期相比下跌9.47%。南下資金淨流入12.32億港幣。
盤面上,互聯網醫療板塊全線走強。阿裏健康漲超12%;醫渡科技漲超4%;平安好醫生、中智全球等多股漲超2%。JD HEALTH , ALI HEALTH Surge 5%-10%, Once at 4-mth Highs。
生物科技板塊暴漲。康方生物-B漲超15%;信達生物漲超13%;騰盛博藥-B、康寧傑瑞製藥-B等多股漲超11%;再鼎醫藥-SB漲超9%。生物醫藥股全線走強,康方生物漲13.66%;摩通微升信達生物目標價至47港元,看好多重利好因素下的增長前景。
醫療設備板塊全線走強。微創醫療漲超10%;華康生物醫學、春立醫療等多股漲超9%;時代天使漲超7%;啓明醫療-B漲超6%。微創醫療漲近3%,分拆公司微創腦科學通過聆訊;春立醫療升逾7%,獲控股股東增持17.45萬股H股;時代天使現漲近9%,醫療機構門診量有望逐步恢復,正畸等需求將釋放。
電力板塊走弱。中電控股跌超7%。花旗下調中電評級至「沽售」,削目標價至56元。
汽車板塊走弱。小鵬汽車-W跌超3%;雅迪控股、理想汽車-W等多股跌超1%。恆生指數收漲0.42%報21163點,“蔚小理”上揚,小鵬汽車漲13.00%。
uSMART智能寫手的信息、數據均來自媒體公開報道,智能寫手不能保證其完全準確,內容僅供參考,不構成投資建議。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.